Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

13.34HKD
2 Jul 2020
Change (% chg)

HK$0.32 (+2.46%)
Prev Close
HK$13.02
Open
HK$13.02
Day's High
HK$13.40
Day's Low
HK$13.00
Volume
3,411,500
Avg. Vol
3,918,504
52-wk High
HK$16.90
52-wk Low
HK$11.30

Latest Key Developments (Source: Significant Developments)

Shanghai Pharmaceuticals Announces Entering Into Land Acquisition And Reserve Agreement
Friday, 15 May 2020 

May 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::CHIATAI QINGCHUNBAO & WEST STREAM VALLEY CONSTRUCTION HEADQUARTER ENTER LAND ACQUISITION & RESERVE AGREEMENT.WEST STREAM VALLEY CONSTRUCTION HEADQUARTER TO PAY RMB2.01 BILLION TO CHIATAI QINGCHUNBAO.EXPECTS TO RECORD ONE-OFF GAIN OF ABOUT RMB1.537 BILLION (BEFORE TAXATION) IN YEAR OF DELIVERY OF TARGET PROPERTIES.PURCHASER TO COMPENSATE LOSSES OF LAND AND PREMISES OF CHIATAI QINGCHUNBAO.  Full Article

Shanghai Pharma's Q1 Net Profit Down 7.8% Y/Y, Plans Funding
Tuesday, 28 Apr 2020 

April 28 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>2607.HK::SAYS Q1 NET PROFIT DOWN 7.8% Y/Y.SAYS IT PLANS TO ISSUE UP TO 10 BILLION YUAN WORTH OF DEBT FINANCING INSTRUMENTS.  Full Article

Shanghai Pharmaceuticals Holding Says FY Profit Attributable RMB4.08 Bln
Friday, 27 Mar 2020 

March 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::FY PROFIT ATTRIBUTABLE RMB4.08 BILLION VERSUS RMB3.88 BILLION.FY REVENUE RMB186.57 BILLION VERSUS RMB159.08 BILLION.PROPOSED CASH DIVIDEND OF RMB4.40 FOR EVERY TEN SHARES.  Full Article

Shanghai Pharma Expects 2019 Net Profit To Decrease Due To Impairment Provision
Friday, 20 Mar 2020 

March 20 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>2607.HK::SAYS IT SETS ASIDE PROVISION FOR GOOD-WILL IMPAIRMENT, EXPECTS TO REDUCE 2019 NET PROFIT BY 477.5 MILLION YUAN ($67.68 million).  Full Article

Guotai Junan Securities Says Units Entered Partnership Deal
Wednesday, 8 Jan 2020 

Jan 8 (Reuters) - Guotai Junan Securities Co Ltd <601211.SS>::UNITS ENTERED PARTNERSHIP DEAL WITH INTERNATIONAL GROUP, SHANGHAI TRUST, JUNJINGHONGFU & OTHER INDEPENDENT THIRD PARTIES.INDEPENDENT THIRD PARTIES UNDER DEAL INCLUDE SHANGHAI PHARMACEUTICALS, SHANGHAI SHANGTOU, SUNING.COM, AMONG OTHERS.  Full Article

Shanghai Pharmaceuticals' 9-Month Net Profit Up 0.8% Y/Y
Wednesday, 30 Oct 2019 

Oct 30 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 2607.HK<601607.SS>::SAYS 9-MONTH NET PROFIT UP 0.8% Y/Y.  Full Article

Shanghai Pharma's Unit To Set Up JV With BIOCAD Holding Hong Kong
Wednesday, 18 Sep 2019 

Sept 18 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>2607.HK::SAYS UNIT SPH PROJECT BIOCAD LTD AGREES TO SET UP JV SPH-BIOCAD (HK) WITH BIOCAD HOLDING HONG KONG.SAYS UNIT TO INVEST $200.4 MILLION IN THE JV FOR 50.1% STAKE.  Full Article

Shanghai Pharmaceuticals' H1 Net Profit Up 12.6% Y/Y
Thursday, 29 Aug 2019 

Aug 29 (Reuters) - Shanghai Pharmaceuticals Holdings Co Ltd<601607.SS>2607.HK: :SAYS H1 NET PROFIT UP 12.6% Y/Y.  Full Article

Shanghai Pharmaceuticals Elects Cho Man As Executive Director Of Seventh Session Of Board
Thursday, 27 Jun 2019 

June 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::CHO MAN, LI YONGZHONG AND SHEN BO WERE ELECTED AS EXECUTIVE DIRECTORS OF SEVENTH SESSION OF BOARD.ZHANG YAOHUA HAVE BEEN APPOINTED AS VICE PRESIDENTS OF CO.  Full Article

Shanghai Pharmaceuticals Says Board Elects Zhou Jun As Chairman
Thursday, 27 Jun 2019 

June 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SAYS BOARD ELECTS ZHOU JUN AS CHAIRMAN.  Full Article

BRIEF-Shanghai Pharmaceuticals' Affiliate To Receive Property Compensation Of 2.0 Bln Yuan

* SAYS ITS AFFILIATE TO RECEIVE PROPERTY COMPENSATION OF 2.0 BILLION YUAN ($281.44 million) Source text in Chinese: https://bit.ly/2WzCFKc Further company coverage: ($1 = 7.1062 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)